Health Care [ 2/12 ] | Pharmaceuticals [ 27/74 ]
NASDAQ | Common Stock
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States.
The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus.
SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 5, 26 | 0.17 Decreased by -65.31% | - |
| May 12, 26 | -0.05 Decreased by -745.61% | - |
| Feb 25, 26 | -0.08 Decreased by -111.83% | - |
| Nov 5, 25 | -0.09 Decreased by -575.40% | - |
| Aug 4, 25 | 0.49 Increased by +1.82 K% | - |
| May 4, 25 | -0.01 Decreased by -103.97% | - |
| Mar 9, 25 | 0.64 Decreased by -36.94% | - |
| Nov 6, 24 | 0.02 Increased by +287.00% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 29, 26 | 41.00 M Decreased by -49.45% | 9.01 M Decreased by -74.61% | Increased by +21.97% Decreased by -49.77% |
| Mar 30, 26 | 6.24 M Decreased by -11.34% | -3.45 M Decreased by -746.17% | Decreased by -55.33% Decreased by -854.37% |
| Dec 30, 25 | 3.80 M Decreased by -95.34% | -5.40 M Decreased by -111.80% | Decreased by -142.11% Decreased by -353.00% |
| Sep 29, 25 | 2.62 M Decreased by -73.83% | -6.37 M Decreased by -573.67% | Decreased by -242.97% Decreased by -1.91 K% |
| Jun 29, 25 | 81.12 M Increased by +271.92% | 35.48 M Increased by +1.84 K% | Increased by +43.74% Increased by +420.59% |
| Mar 30, 25 | 7.04 M Decreased by -72.31% | -408.22 K Decreased by -103.97% | Decreased by -5.80% Decreased by -114.35% |
| Dec 30, 24 | 81.47 M Decreased by -30.06% | 45.76 M Decreased by -36.67% | Increased by +56.17% Decreased by -9.45% |
| Sep 29, 24 | 10.01 M Increased by +8.39% | 1.34 M Increased by +441.91% | Increased by +13.43% Increased by +415.45% |